Previsão

Comprar	1
Manter	2
Vender	0

Notícias Ir para o feed de notícias

Charlotte’s Web appoints Jeff Raborn to board of directors

Charlotte’s Web has appointed Jeff Raborn, Executive Vice President Law & External Affairs and General Counsel at Reynolds American (a BAT subsidiary), to its board effective May 28. The nomination was made by BT DE Investments, a subsidiary of British American Tobacco, as part of an agreed transaction and increases the board to seven members. Raborn brings extensive experience in law, regulation and corporate governance for highly regulated consumer goods industries, strengthening the company amid an increasingly dynamic regulatory environment. » Mais em de.investing.com
Charlotte's Web Holdings: Q2 2025 revenue beats expectations, stock remains steady

Charlotte's Web Holdings Inc. reported Q2 2025 revenue of $12.8 million, beating expectations, while EPS of -$0.04 missed estimates. The net loss narrowed significantly and the stock was steady in premarket trading; management is targeting positive cash flow by 2026. Product innovations and expanded distribution channels are expected to support further growth. » Mais em de.investing.com
Charlotte’s Web grants $750,000 loan to DeFloria joint venture

Charlotte’s Web Holdings has provided a $750,000 loan to the joint venture DeFloria Inc., which was established together with AJNA BioSciences and a subsidiary of British American Tobacco. The loan is due by the end of 2026 at the latest or upon a larger financing round, with Charlotte’s Web entitled to exercise contractual rights in the event of default. No further financial details were disclosed in the publicly available portion of the SEC filing. » Mais em de.investing.com

Dados financeiros da empresa

No último trimestre, CHARLOTTES WEB HLDGS registou receitas de € 9,51 mi e um ganho líquido de -€ 3,62 mi

(EUR)	junho de 2026	YoY
Receitas	9,51 mi	12,46%
Ganho bruto	4,52 mi	11,09%
Ganho líquido	-3,62 mi	32,22%
EBITDA	-2,51 mi	16,89%

Dados fundamentais

Métrica	Valor
Capitalização bolsista	€ 82,1 mi
Número de ações	270,55 mi
Máximo/mínimo de 52 semanas	€ 0,84 - € 0,065
Dividendos	Não
Beta	2,27
PER (PE Ratio)	-1,65
PEG (PEG Ratio)	0,04
P/VC (PB Ratio)	0,99
P/V (PS Ratio)	2,02

Perfil da empresa

Charlotte's Web Holdings, Inc. beschäftigt sich mit dem Anbau, der Herstellung, dem Marketing und dem Verkauf von aus Hanf gewonnenen Cannabidiol (CBD)-Wellnessprodukten. Zu den Produktkategorien des Unternehmens gehören Hanfextrakt-Öl-Tinkturen, wie z. B. flüssige Produkte; Gummibärchen, die Produkte für Schlaf, Stress, Immunität und Trainingserholung umfassen; und Kapseln, CBD-Cremes und -Lotionen sowie Produkte für Haustiere unter den Marken Charlotte's Web, CBD Medic, CBD Clinic und Harmony Hemp. Seine Produkte enthalten natürlich vorkommende Phytocannabinoide, darunter CBD, Cannabichromen, Cannabigerol, Cannabinol, Terpene, Flavonoide und andere nützliche Hanfverbindungen. Das Unternehmen vertreibt seine Produkte über Einzelhandelsgeschäfte und Heilpraktiker sowie online über seine Website. Es besteht eine Zusammenarbeit zwischen seiner wissenschaftlichen Abteilung CW Labs und dem Center for Integrated Global Biomedical Sciences der University at Buffalo, um die Hanf-Cannabinoid-Wissenschaft durch ein Forschungsprogramm voranzutreiben, sowie eine wissenschaftliche Zusammenarbeit mit dem McLean Hospital. Das Unternehmen war früher als Stanley Brothers Holdings Inc. bekannt und änderte im Juli 2018 seinen Namen in Charlotte's Web Holdings, Inc. Charlotte's Web Holdings, Inc. wurde im Jahr 2013 gegründet und hat seinen Hauptsitz in Denver, Colorado.

Nome	CHARLOTTES WEB HLDGS
CEO	William Morachnick
Sede	Louisville, co EUA
Site	charlottesweb.com
Indústria	Produtos alimentares
Entrada em bolsa	13/09/2018
Colaboradores	112